CohBar is a clinical-stage biotechnology company focused on the research and development of mitochondria based therapeutics. It aims to treat a range of diseases associated with aging and metabolic dysfunction including non-alcoholic steatohepatitis (NASH), obesity, type 2 diabetes, cancer, cardiovascular and neurodegenerative diseases.